233 related articles for article (PubMed ID: 17138133)
21. The role of imaging in the surveillance of urologic malignancies.
Bradford TJ; Montie JE; Hafez KS
Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
[TBL] [Abstract][Full Text] [Related]
22. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
23. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
[TBL] [Abstract][Full Text] [Related]
24. The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer.
Gonzalgo ML; Datar RH; Schoenberg MP; Cote RJ
Urol Oncol; 2007; 25(3):228-35. PubMed ID: 17483020
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers.
Ahmed FE
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):101-54. PubMed ID: 17558783
[TBL] [Abstract][Full Text] [Related]
26. Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
Christoph F; Hinz S; Weikert S; Kempkensteffen C; Schostak M; Miller K; Schrader M
Urol Int; 2008; 80(4):398-404. PubMed ID: 18587251
[TBL] [Abstract][Full Text] [Related]
27. Molecular markers for detection, surveillance and prognostication of bladder cancer.
Vrooman OP; Witjes JA
Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
29. Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
Aveta A; Cilio S; Contieri R; Spena G; Napolitano L; Manfredi C; Franco A; Crocerossa F; Cerrato C; Ferro M; Del Giudice F; Verze P; Lasorsa F; Salonia A; Nair R; Walz J; Lucarelli G; Pandolfo SD
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446024
[TBL] [Abstract][Full Text] [Related]
30. Human urologic cancer cell lines.
Williams RD
Invest Urol; 1980 Mar; 17(5):359-63. PubMed ID: 6244232
[No Abstract] [Full Text] [Related]
31. Urological malignancies and the proteomic-genomic interface.
Unwin RD; Knowles MA; Selby PJ; Banks RE
Electrophoresis; 1999 Dec; 20(18):3629-37. PubMed ID: 10612290
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation and cancer diagnosis: new methods and applications.
Dehan P; Kustermans G; Guenin S; Horion J; Boniver J; Delvenne P
Expert Rev Mol Diagn; 2009 Oct; 9(7):651-7. PubMed ID: 19817550
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells.
Park JJ; Kang JK; Hong S; Ryu ES; Kim JI; Lee JH; Seo JS
Gene; 2008 Jan; 407(1-2):139-47. PubMed ID: 17997235
[TBL] [Abstract][Full Text] [Related]
34. Molecular therapy in urologic oncology.
Froehner M; Hakenberg OW; Wirth MP
Urol Int; 2007; 79(1):1-7. PubMed ID: 17627159
[TBL] [Abstract][Full Text] [Related]
35. Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer.
Johanneson B; Deutsch K; McIntosh L; Friedrichsen-Karyadi DM; Janer M; Kwon EM; Iwasaki L; Hood L; Ostrander EA; Stanford JL
Prostate; 2007 May; 67(7):732-42. PubMed ID: 17372923
[TBL] [Abstract][Full Text] [Related]
36. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
[TBL] [Abstract][Full Text] [Related]
37. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
van der Kwast TH; Bapat B
Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
[TBL] [Abstract][Full Text] [Related]
38. Nucleic acid-based tissue biomarkers of urologic malignancies.
Dietrich D; Meller S; Uhl B; Ralla B; Stephan C; Jung K; Ellinger J; Kristiansen G
Crit Rev Clin Lab Sci; 2014 Aug; 51(4):173-99. PubMed ID: 24878394
[TBL] [Abstract][Full Text] [Related]
39. [What are the contributions of experimental studies to the diagnosis and therapy of urological tumors?].
Debruyne FM; Oosterhof GO; Schalken JA
Verh K Acad Geneeskd Belg; 1991; 53(1):29-37; discussion 38. PubMed ID: 2053419
[TBL] [Abstract][Full Text] [Related]
40. Primary care update on kidney and bladder cancer: a urologic perspective.
Droller MJ
Med Clin North Am; 2004 Mar; 88(2):309-28, x. PubMed ID: 15049580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
